FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula 
, which inhibit serine protease activity, particularly hepatitis C virus NS3-NS4A protease. The compounds act by inhibiting the life cycle of the hepatitis C virus, and can also be used as antiviral agents. The invention also relates to compositions containing said compounds, or for use in vivo or for administration to patient suffering from HCV infection.
EFFECT: high efficiency of using the composition.
35 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INHIBITORS OF SERINE PROTEASES, IN PARTICULAR, HC-3-HC4A PROTEASE | 2004 |
|
RU2412198C2 |
| DERIVATIVES OF 3-[2-(3-ACYLAMINO-2-OXO-2H-PYRIDIN-1-YL)-ACETYLAMINO]-4-OXO-PENTANE ACID AND THEIR APPLICATION AS CASPASE INHIBITORS | 2005 |
|
RU2412936C2 |
| CASPASE INHIBITORS AND USE THEREOF | 2004 |
|
RU2372335C2 |
| SERINE-THREONINE PROTEIN KINASE AND PARP MODULATORS | 2013 |
|
RU2681209C2 |
| PRODRUG 1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES | 2003 |
|
RU2357962C2 |
| SERINE PROTEASE INHIBITORS | 2006 |
|
RU2441020C2 |
| METHOD FOR REGIOSELECTIVE SYNTHESIS OF 1-ALKYL-3-HALOGENALKYLPYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES | 2009 |
|
RU2498978C2 |
| CASPASE INHIBITOR PRODRUGS | 2006 |
|
RU2427582C2 |
| DEUTERATED HEPATITIS C PROTEASE INHIBITORS | 2007 |
|
RU2465264C2 |
| AZAINDOLES, USEFUL AS INHIBITORS OF JAK AND OTHER PROTEINKINASES | 2005 |
|
RU2403252C2 |
